Desq Long
Sign in

Company

TENAX THERAPEUTICS, INC.

TENX · CIK 0000034956

SEC FORM 4CLUSTER · 3 INSIDERS
$132,828.31

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 69,525 shares across 3 reporting persons.

Transaction Code P · Reporting Persons 3

  • STAAB THOMAS R II, Chief Financial OfficerPurchase of 5,675 shares at $1.935 per share.$10,981.13
  • Giordano Christopher Thomas, CEOPurchase of 6,000 shares at $1.875 per share.$11,250.00
  • Giordano Christopher Thomas, CEOPurchase of 4,850 shares at $1.8221 per share.$8,837.18
  • Doogan DeclanPurchase of 53,000 shares at $1.92 per share.$101,760.00

Surfaced by rule: 3 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 11, 2026 · Disclosed Sep 17, 2026FILED +6 DAYS

Source: SEC Form 4 · 0001193125-26-392319 · filed 2026-09-15 · View filing →

Source: SEC Form 4 · 0001871714-26-000002 · filed 2026-09-15 · View filing →

Source: SEC Form 4 · 0001193125-26-394831 · filed 2026-09-17 · View filing →

SEC FORM 4
$1,604,160.00

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 900,000 shares at $1.7824 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001940272-26-000020 · filed 2026-09-08 · View filing →

SEC FORM 4
$337,585.64

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 187,704 shares at $1.7985 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Sep 2, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001940272-26-000019 · filed 2026-09-02 · View filing →

SEC FORM 4
$321,570.26

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 179,058 shares at $1.7959 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001940272-26-000019 · filed 2026-09-02 · View filing →

SEC FORM 4
$722,593.88

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 403,571 shares at $1.7905 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001940272-26-000019 · filed 2026-09-02 · View filing →

SEC FORM 4
$188,355.47

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 107,374 shares at $1.7542 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Aug 24, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001940272-26-000017 · filed 2026-08-24 · View filing →

SEC FORM 4
$1,266,253.84

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 716,369 shares at $1.7676 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001940272-26-000017 · filed 2026-08-24 · View filing →

SEC FORM 4
$359,538.17

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 202,124 shares at $1.7788 per share.

Reporting Persons ADAR1 Capital Management, LLC · Schneeberger Daniel · Transaction Code P

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001940272-26-000017 · filed 2026-08-24 · View filing →